Quick Answer
Fresenius Medical Care AG reported Cash and Equivalents of $747.23 million for fiscal year 2016.
Fresenius Medical Care AG Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2016 | $747.23M | +36.0% |
| 2015 | $549.50M | -13.3% |
| 2014 | $633.86M | -7.2% |
| 2013 | $682.78M | -0.8% |
| 2012 | $688.04M | +50.5% |
| 2011 | $457.29M | -12.5% |
| 2010 | $522.87M | +73.6% |
| 2009 | $301.23M | +35.9% |
| 2008 | $221.58M | -9.4% |
| 2007 | $244.69M | +53.9% |
| 2006 | $159.01M | — |
- Fresenius Medical Care AG showed an increase of +36.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2006–2016 period, Fresenius Medical Care AG’s cash and equivalents has grown by 369.9% (from $159.01 million to $747.23 million).
- The most recent figure is from Fresenius Medical Care AG’s fiscal year 2016 report (Form 20-F), filed with the SEC on February 22, 2017.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: